Onexio Biosystems

Onexio Biosystems is listed as a new startup research supplier in the Scientist.com network, with 1 site in 1 country.

Search companies, drugs, suppliers and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Sites 1

Countries 1

Type of company: New startup

Cell Culture Culture primary or immortalized cell lines.
Organotypic Culture Co-culture different cells to enable in vitro growth of an in vivo tissue or organ equivalent.

Natural Product Screening Screen large natural product collections for therapeutic activity.

Metabolic Stability in Hepatocytes Assess the susceptibility of drugs to metabolism by Phase I (CYP450) and Phase II enzymes in liver cells.
Metabolite Synthesis Synthesize drug metabolites that are formed after administration of drug to an animal model or patient.

High Content Screening Analyze whole cells or components of cells with simultaneous readout of several parameters.
HTS Assay Development Develop assays to use in high throughput screening.
Phenotype Assays Measure effects of drug candidate on the morphology or function of cells and whole animals.

Drug Target Assays Gain insight into the selectivity and mode-of-action of a compound's pharmacological targets.
High Throughput Screening Conduct millions of chemical, genetic or pharmacological tests in a short period of time.

Safety Pharmacology Assess the impact of a therapeutic for human use on vital organ systems before first-in-man drug testing.

Work with Onexio Biosystems on Scientist.com

For prices, more details, or to contact Onexio Biosystems, visit Scientist.com.